AXIM · Axim Biotechnologies, Inc. · Exempt Offerings
$0.00
+0.00 (+5.56%)
At close · Sep 4
Going-concern doubt
— flagged Aug 19, 2024
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include any adjustments related to the recoverability of assets and classification of liabilities that might be necessary should the Company be unable to continue in operation.”View the 10-Q filed Aug 19, 2024
Market Cap
$1.21M
Shares
301.96M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.